Overview of IMBiotechnologies

IMBiotechnologies is a Canadian-based medical device company specializing in therapeutic embolization products for embolotherapy, a minimally invasive treatment used in interventional radiology to destroy unresectable/inoperable hypervascularized tumors.  IMB’s mission is to create and commercialize innovative products that treat disease and improve quality of life.

Ekobi ™ Microspheres are Biodegradable, Hyperechoic and Effective

Ekobi is a first-in-class biodegradable embolic agent that is detectable by ultrasound for the treatment conditions such as kidney and liver cancer, enlarged prostates and uterine fibroids. Ekobi Microspheres are delivered through a catheter into blood vessels that feed a target tissue and selectively block the tissue’s blood supply. The tissue is either destroyed or devitalized.

Biodegradable

• Microspheres biodegrade and are completely eliminated from the body in 4-6 months, unlike other embolic agents
• Made from PLGA, an established and safe polymer
• Safely breaks down into carbon dioxide and water

Hyperechoic

• Real-time microsphere detection with standard ultrasound
• Detectable during procedure and post-procedure
• Potential to reduce fluoroscopy timer

Enhanced Clotting Mechanism

• Binds the patient’s circulating platelets
• Promotes efficient clot formation

Ekobi is provided as dry, free-flowing powder in a sterile vial and is available in a range of calibrated sizes.

For more information about Ekobi Microspheres from IMBiotechnologies, email Kelly Mottett or visit imbiotechnologies.com.